Molecular scissors help cancer cells break out and spread

September 29, 2006

A University of Michigan research team has identified how cancer cells employ a sort of molecular scissors to cut their way out of tumors and begin spreading throughout the body.

This spread of cancer cells, called metastasis, marks a turning point in the progression of the disease, after which treatment and recovery become more difficult.

"We asked how cancer cells cut their way through tissues," said Stephen Weiss, Life Sciences Institute research professor and division chief, molecular medicine and genetics in the U-M Medical School. "They use what we call proteases, a type of molecular scissors. However, there are so many different types of these scissors encoded by the human genome, we wanted to focus our attention on finding the subset used by cancers."

In all forms of cancer, a hallmark of malignancy is the tumor's ability to penetrate the basement membrane, a specialized connective tissue that lines the internal and external surfaces of the body including blood vessels, nerves, muscle and fat. Of the more than 500 enzymes that could be used by cells as molecular scissors, the Weiss team found that three proteases, termed MT1-MMP, MT2-MMP and MT3-MMP, are the most likely candidates that regulate cancer cell invasion.

The tumor cells appear to use these three enzymes to cut their way through the basement membrane, thus allowing cancer cells access to blood vessels which act as conduits for the spread of malignant cells to distant sites in the body.

"These closely related proteases allow cancer cells to start eating through basement membranes and the surrounding tissues," Weiss said. "This is the first critical step in the malignant process and allows the rapid spread of cancer cells through the body."

By identifying this set of proteases, the studies by Weiss and his colleagues have provided the first known proof that a small set of genes and proteins may underlie the cancer cell metastatic process. While their work is still at an early stage, the researchers are attempting to develop new inhibitors of these proteases so that they could test their importance in animal models of human cancer.

"A cancer cell metalloprotease triad regulates the basement membrane transmigration program," by Kevin Hotary, Xiao-Yan Li, Edward Allen, Susan L. Stevens and Stephen J. Weiss, appears as an advanced online publication in the journal Genes & Development and in print on Oct. 1, 2006.

Source: University of Michigan

Explore further: Tailoring treatment to combat diseased cells at the genetic level

Related Stories

Tailoring treatment to combat diseased cells at the genetic level

December 4, 2017
A new drug delivery system that uses a synthetic-biological hybrid nanocapsule could provide a smart technology for targeted treatment of a variety of serious diseases at the genetic level.

A rare disease inspires a new way to attack cancer

October 25, 2017
Some of the most promising new treatments for blood cancers, drugs called proteasome inhibitors, have a problem: For reasons that researchers are still working to fully understand, cancer cells can build up a resistance to ...

How Helicobacter pylori causes gastric cancer

November 7, 2017
Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization (WHO), about 750,000 patients die each year after developing the disease. The main cause is thought ...

Researchers identify enzyme linked to prostate cancer

December 18, 2012
Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic ...

Virus shows promise as prostate cancer treatment

February 25, 2013
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...

HIV drug shows efficacy in treating mouse models of HER2+ breast cancer

October 6, 2012
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of the ...

Recommended for you

Scientists discover possible master switch for programming cancer immunotherapy

December 11, 2017
During infection or tumor growth, a type of specialized white blood cells called CD8+ T cells rapidly multiply within the spleen and lymph nodes and acquire the ability to kill diseased cells. Some of these killer T cells ...

A new weapon against bone metastasis? Team develops antibody to fight cancer

December 11, 2017
In the ongoing battle between cancer and modern medicine, some therapeutic agents, while effective, can bring undesirable or even dangerous side effects. "Chemo saves lives and improves survival, but it could work much better ...

Insights on how SHARPIN promotes cancer progression

December 11, 2017
Researchers at Sanford Burnham Prebys Medical Discovery (SBP) and the Technion in Israel have found a new role for the SHARPIN protein. In addition to being one of three proteins in the linear ubiquitin chain assembly complex ...

Glioblastoma survival mechanism reveals new therapeutic target

December 11, 2017
A Northwestern Medicine study, published in the journal Cancer Cell, has provided new insights into a mechanism of tumor survival in glioblastoma and demonstrated that inhibiting the process could enhance the effects of radiation ...

Liver cancer: Lipid synthesis promotes tumor formation

December 11, 2017
Lipids comprise an optimal energy source and an important cell component. Researchers from the Biozentrum of the University of Basel and from the University of Geneva have now discovered that the protein mTOR stimulates the ...

Use of chemotherapy for early stage breast cancer declines, study says

December 11, 2017
A study of nearly 3,000 women with early stage breast cancer indicates a recent, significant decline in the use of chemotherapy despite the lack of any change in national treatment recommendations or guidelines, according ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.